{"id":"https://openalex.org/W166855412","doi":"https://doi.org/10.1007/978-1-4939-2450-9_15","title":"Antimicrobial Susceptibility Testing for Mycobacterium sp.","display_name":"Antimicrobial Susceptibility Testing for Mycobacterium sp.","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W166855412","doi":"https://doi.org/10.1007/978-1-4939-2450-9_15","mag":"166855412","pmid":"https://pubmed.ncbi.nlm.nih.gov/25779321"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-4939-2450-9_15","doi":"https://doi.org/10.1007/978-1-4939-2450-9_15","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4939-2450-9_15","pdf_url":null,"source":{"id":"https://openalex.org/S4210172139","display_name":"Methods in molecular biology","issn_l":"1064-3745","issn":["1064-3745","1940-6029"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods in Molecular Biology","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4254421250","display_name":"Mycobacteria Protocols"},"type":"book-chapter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088094208","display_name":"Delia Blanco-Ruano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Delia Blanco-Ruano","raw_affiliation_strings":["Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David M. Roberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330732676","display_name":"Infectious Disease Research Institute","ror":"https://ror.org/03y4myd35","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1330732676"]},{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES","US"],"is_corresponding":false,"raw_author_name":"David M. Roberts","raw_affiliation_strings":["Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","Infectious Disease Research Inst (IDRI), Seattle, Washington, USA","TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","institution_ids":["https://openalex.org/I4210151147"]},{"raw_affiliation_string":"Infectious Disease Research Inst (IDRI), Seattle, Washington, USA","institution_ids":["https://openalex.org/I1330732676"]},{"raw_affiliation_string":"TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, USA","institution_ids":["https://openalex.org/I1330732676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052144881","display_name":"Rub\u00e9n Gonz\u00e1lez del R\u00edo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ruben Gonzalez-Del-Rio","raw_affiliation_strings":["Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Daniel \u00c1lvarez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel \u00c1lvarez","raw_affiliation_strings":["Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108338680","display_name":"Ma Jos\u00e9 Rebollo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M\u00aa Jos\u00e9 Rebollo","raw_affiliation_strings":["Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009433918","display_name":"Esther P\u00e9rez\u2010Herr\u00e1n","orcid":"https://orcid.org/0000-0002-4464-9528","observed_orcids":["https://orcid.org/0000-0002-4464-9528"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Esther P\u00e9rez-Herr\u00e1n","raw_affiliation_strings":["Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040757128","display_name":"Alfonso Mendoza-Losana","orcid":"https://orcid.org/0000-0003-2493-4118","observed_orcids":["https://orcid.org/0000-0003-2493-4118"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Alfonso Mendoza","raw_affiliation_strings":["Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of the Developing World, Tres Cantos Medicines Development Campus, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid, 28760, Spain","institution_ids":["https://openalex.org/I4210151147"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040757128"],"corresponding_institution_ids":["https://openalex.org/I4210151147"],"apc_list":null,"apc_paid":null,"fwci":10.5153,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.97567031,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"1285","issue":null,"first_page":"257","last_page":"268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.4684999883174896,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.4684999883174896,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.399399995803833,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.09939999878406525,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antimicrobial-susceptibility-testing","display_name":"antimicrobial susceptibility testing","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mycobacterium","display_name":"Mycobacterium","score":0.9950000047683716},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.765999972820282},{"id":"https://openalex.org/keywords/medium-throughput-screening","display_name":"medium-throughput screening","score":0.925000011920929},{"id":"https://openalex.org/keywords/antibiotic-activity","display_name":"antibiotic activity","score":0.621999979019165},{"id":"https://openalex.org/keywords/clinical-microbiology","display_name":"clinical microbiology","score":0.6830000281333923},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.7317721843719482},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.5286453366279602},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5186026096343994},{"id":"https://openalex.org/C2992965680","wikidata":"https://www.wikidata.org/wiki/Q598976","display_name":"Clinical microbiology","level":2,"score":0.5097660422325134},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4999096393585205},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43313339352607727},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33880096673965454},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.041860431432724}],"mesh":[{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000890","descriptor_name":"Anti-Infective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003470","descriptor_name":"Culture Media","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D009161","descriptor_name":"Mycobacterium","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009161","descriptor_name":"Mycobacterium","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D009161","descriptor_name":"Mycobacterium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010101","descriptor_name":"Oxygen Consumption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/978-1-4939-2450-9_15","doi":"https://doi.org/10.1007/978-1-4939-2450-9_15","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4939-2450-9_15","pdf_url":null,"source":{"id":"https://openalex.org/S4210172139","display_name":"Methods in molecular biology","issn_l":"1064-3745","issn":["1064-3745","1940-6029"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods in Molecular Biology","raw_type":"book-chapter"},{"id":"pmid:25779321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25779321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods in molecular biology (Clifton, N.J.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W2000759029","https://openalex.org/W2022132013","https://openalex.org/W2034080889","https://openalex.org/W2058580259","https://openalex.org/W2073125281","https://openalex.org/W2094879924","https://openalex.org/W2116624771","https://openalex.org/W2127686872","https://openalex.org/W2160787060","https://openalex.org/W2162151914","https://openalex.org/W2166142530"],"related_works":["https://openalex.org/W3181248117","https://openalex.org/W4385735505","https://openalex.org/W2118744879","https://openalex.org/W4243500137","https://openalex.org/W575726480","https://openalex.org/W3208566228","https://openalex.org/W2109684694","https://openalex.org/W1862873502","https://openalex.org/W6885154207","https://openalex.org/W2188050953"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}